JPRN-UMIN000036837招募中未知
Examination of efficacy and safety treated by romosozumab or denosumab in osteoporosis with collagen disease including glucocorticoid-induced osteoporosis - Efficacy and safety treated by romosozumab or denosumab in osteoporosis with collagen disease including GIO
Shinshu University School of Medicine Dept. of Orthopaedic Surgery0 个研究点目标入组 60 人开始时间: 2019年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1:Patients who have taken romosozumab or denosumab before 2:Patients who are allergic to romosozumab or denosumab or eldecalcitol 3:Hypocalcemia 4:Pregnant or breast-feeding patients 5:Patients with severe renal function (eGFR 30 ml / min / 1.73 m2) or patients undergoing dialysis 6:Patients at risk of hypercalcemia (patients with renal dysfunction, patients with malignancy, patients with primary hyperparathyroidism) 7:Patients with severe liver dysfunction 8:Patients with urolithiasis and patients with a history of their history 9:Others, patients judged by the research director as inappropriate
研究者
相似试验
尚未招募
不适用
Examination of efficacy and safety treated by Mirogabalin in patients with peripheral neuropathy in Orthopaedic diseasePatients with peripheral neuropathy in Orthopaedic diseasesJPRN-UMIN000037150Dept. of Orthopaedic Surgery Shinshu University School of Medicine60
已完成
不适用
The evaluation of the efficacy and the safety of rikkunshito on anorexia in Parkinson's disease patientsJPRN-UMIN000009626Saitama Medical Center,Saitama Medical University20
招募中
不适用
The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patientsElderly dementia patientsJPRN-UMIN000011198Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine20
招募中
不适用
Examination of efficacy and safety treated by denosumab or zoledronate in glucocorticoid-induced osteoporosisJPRN-UMIN000035844Dept. of Orthopaedic Surgery Shinshu University School of Medicine60
尚未招募
不适用
Evaluation of the efficacy and safety of romosozumab alone and romosozumab + denosumab combination for patients with osteoporosis treated with 2-year denosumabosteoporosisJPRN-UMIN000037123Shinshu University School of Medicine Dept. of Orthopaedic Surgery60